In contrast, SAMM50 and TOMM20 had hazard ratios less than 1, indicating potential protective effects, although their p-values (0.098 and 0.051, respectively) did not reach statistical significance.
← all excerpts
CRISPR-Cas9 screening identifies a gene signature predictive of prognosis in glioblastoma.
1
—
—